Quark Pharmaceuticals, Inc. Company Profile

14:24 EDT 26th September 2017 | BioPortfolio

News Articles [1284 Associated News Articles listed on BioPortfolio]

Quark Pharmaceuticals Reports Positive Phase 2 Results to Evaluate the Efficacy and Safety of QPI-1002

NewsThe study included 341 subjects of age 45 or greater undergoing cardiac surgery and at risk for AKI.

Quark Pharmaceuticals Inc. Reports Positive Results From A Phase II Study To Evaluate The Efficacy And Safety Of QPI-1002 For The Prevention Of Acute Kidney Injury (AKI) In Subjects At High Risk Of AKI Following Cardiac Surgery

  Life Sciences Jobs   ...

Silence Therapeutics notes positive Phase II study results by licensee Quark Pharmaceutical for prevention of Acute Kidney Injury

Silence Therapeutics (LON:SLN) noted today that its licensee Quark Pharmaceutical Inc has reported positive results from a Phase 2 Study to evaluate the efficacy and safety of its QPI-1002 therapy for...

Eloxx brings in first $5mm of $24mm Series C

Israeli biotech Eloxx Pharmaceuticals Ltd. (focused on genetic diseases caused by nonsense mutations) raised $5mm from Quark Venture and GF Securities (through their Global Health Science Fund) as the...

Silence Therapeutics eyes late stage payments as it widens patent net for gene silencing tech

Silence Therapeutics PLC (LON:SLN) has filed for more patent protection for its RNA therapeutics/gene silencing technology and intends to seek payment for a number of  drugs already in late-stage...

Quark's QPI-1002 meets Phase II kidney injury endpoint

Quark siRNA meets Phase II kidney injury endpoint

Eloxx Pharmacueticals Receives A US$5 Million Investment from Quark Venture and GF Securities to Advance A Novel Disease-Modifying Therapy Targeting Genetic Diseases

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/08/17 -- Today, Quark Venture Inc. and GF Securities announced a $US5 million investment Eloxx Pharmaceuticals through their Global Health Science ...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [169 Associated PubMed Articles listed on BioPortfolio]

Detection of magnetized quark-nuggets, a candidate for dark matter.

Quark nuggets are theoretical objects composed of approximately equal numbers of up, down, and strange quarks and are also called strangelets and nuclearites. They have been proposed as a candidate fo...

Proper time regularization and the QCD chiral phase transition.

We study the QCD chiral phase transition at finite temperature and finite quark chemical potential within the two flavor Nambu-Jona-Lasinio (NJL) model, where a generalization of the proper-time regul...

Constraining Light-Quark Yukawa Couplings from Higgs Distributions.

We propose a novel strategy to constrain the bottom and charm Yukawa couplings by exploiting Large Hadron Collider (LHC) measurements of transverse momentum distributions in Higgs production. Our meth...

Small-x Asymptotics of the Quark Helicity Distribution.

We construct a numerical solution of the small-x evolution equations derived in our recent work [J. High Energy Phys. 01 (2016) 072.JHEPFG1029-847910.1007/JHEP01(2016)072] for the (anti)quark transver...

Five-Loop Running of the QCD Coupling Constant.

We analytically compute the five-loop term in the beta function which governs the running of α_{s}-the quark-gluon coupling constant in QCD. The new term leads to a reduction of the theory uncertaint...

Clinical Trials [200 Associated Clinical Trials listed on BioPortfolio]

The ICALIC International Multicentric Study

This study will evaluate the ease of use of the new calorimeter (Quark RMR 2.0 (COSMED, Italy)) in intensive care unit (ICU) patients compared to currently used calorimeters (i.e. Quark RM...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1280 Associated Companies listed on BioPortfolio]

Quark Biotech, Inc.

Quark Biotech, Inc., is a biopharmaceutical company headquartered in the U.S., focused on the development of drugs based in its proprietary target genes.Quark has developed a broad technology portfoli...

Quark Pharmaceuticals, Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Quark Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Quark Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Quark Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Quark Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quark Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Quark Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record